✦ LIBER ✦

Single-Institution Experience With Radium-223 Dichloride (Ra-223) for Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

✍ Scribed by Cox, B.W.; Wang, L.; Bradley, T.; Gu, B.; Kelley, K.; Potters, L.

Book ID: 126730846
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 51 KB
Volume: 90
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2014.05.1462

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Observations From Early Adoption of Radi

Observations From Early Adoption of Radium 223 (Ra-223) in Heavily Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

✍ McHaffie, D.R.; Sharp, H.J.; Symanowski, J.; Crimaldi, A.J.; Mahoney, J.; Burges 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Estimating the Economic Impact of Radium

Estimating the Economic Impact of Radium Ra 223 Dichloride (Radium-223) in Treatment of Castration-Resistant Prostate Cancer (CRPC) with Symptomatic Bone Metastases and No Known Visceral Metastatic Disease

✍ Valderrama, A.; Bilir, S.P.; Wehler, E.A.; Seal, B.S.; Wen, L.; Yaldo, A.; Munak 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

MP70-01 EARLY EXPERIENCE OF RADIUM-223 T

MP70-01 EARLY EXPERIENCE OF RADIUM-223 TREATMENT FOR METASTATIC CASTRATE RESISTANT PROSTATE CANCER: A PRELIMINARY REPORT

✍ Bienz, Marc; Alom, Modar; Mouravieva, Vladimira; Zehel, Debby; Pieczonka, Christ 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 188 KB

Phase I pharmacokinetic and biodistribut

Phase I pharmacokinetic and biodistribution study with escalating doses of223Ra-dichloride in men with castration-resistant metastatic prostate cancer

✍ Carrasquillo, Jorge A.; OâDonoghue, Joseph A.; Pandit-Taskar, Neeta; Humm, Joh 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 426 KB

Radium-223 Dichloride: A Review of Its U

Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases

✍ Shirley, Matt; McCormack, Paul L. 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 419 KB

P124 Long-term safety of radium-223 dich

P124 Long-term safety of radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases from the phase 3 ALSYMPCA study

✍ Nilsson, S; Schrader, A.J.; Kliment, J.; Solberg, A.; Franzén, L.; Bottomley, D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB